Skip to search formSkip to main contentSkip to account menu

mirogabalin

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Bridged Bicyclo Compounds

Narrower (1)

DS-5565

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
[Analgesic Effects of Mirogabalin for Cancer Pain].
Mirogabalin is a novel drug for alleviating peripheral neuropathic pain, available since April 2019 in Japan. Since cancer pain… 
2019
2019
[Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige® tablets 2.5 mg∙5 mg∙10 mg∙15 mg)].
Mirogabalin, a novel ligand for the α2δ subunit of voltage-gated calcium channels, has been approved for the treatment of… 
2019
2019
Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients: Erratum.
  • Pain
  • 2019
  • Corpus ID: 198192348
2018
2018
Target : Calcium Channel Pathway : Membrane Transporter / Ion Channel Solubility : DMSO : 10 mM
  • 2018
  • Corpus ID: 49231483
BIOLOGICAL ACTIVITY: Mirogabalin (DS-5565) is a novel, preferentially selective α2δ-1 ligand characterized by high potency and… 
2016
2016
Exposure–response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS‐5565) in patients with diabetic peripheral neuropathic pain
Mirogabalin (DS‐5565) is an α2δ‐1 ligand being developed for pain associated with diabetic peripheral neuropathy, fibromyalgia… 
2015
2015
Diabetische Polyneuropathie – Mirogabalin mindert polyneuropathische Schmerzen
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)